ReachX logo

Japan Hospice (TYO: 7061) - Fundamental Investment Case

Research

Publication Date: 13 Sep 2019 - By Rowan Ewart-White By Rowan Ewart-White
Actionable
Differentiated

Equity Fundamental Equity Asia ex-China Healthcare

For a nation with a demographic crisis Japan has remarkably few hospices, in spite of their cost and convenience advantages. Japan Hospice is ideally placed to change that.

The Japanese hospice market is a nascent industry, with none of the major three operators over a decade old. We expect the combination of a rising death rate, medical system pressures incentivising hospitals towards rapid discharge and terminal patients increasingly choosing palliative care to generate significant and sustainable demand.

Japan Hospice can receive approximately Y1m in sales per person per month (of which the patient pays Y200k), or approximately three times that of a typical elderly care home.

Japan Hospice Fundamental Hospice Case

Source: Storm Research

Pages: 7

Released: 13 Sep 2019

Unlock for 5 credits

The Author

Rowan Ewart-White

Consulting

Fintech, Industrials, Automotive, Pharmaceuticals, Consumer, Telecom & Media, Technology, Materials, Construction, Financial Services, Real Estate, Transport, Healthcare

Book

 

Most read

ReachX
1-15 Clere Street, EC2A 4UY
London, United Kingdom
info@reachx.co
ReachX
1-15 Clere Street, EC2A 4UY
London, United Kingdom

info@reachx.co
Sign up to our newsletter